SHIPPING ABOVE €200
SinglePheromones.com
e-mail: [email protected]
e-mail: [email protected]
CHRISTMAS BIG SALE
Intense Desire This Christmas!
Save up to 20%!
Individual differences in sensitivity to the putative human pheromone androstadienone were investigated in three experiments. In experiment 1, the absolute detection threshold for androstadienone was determined to be 211 µM using the method of constant stimuli. Detection for the related compound estratetraenol was also investigated but a threshold could not be determined. In experiment 2, using an adaptive threshold test on 100 participants, the sensitivity distribution for androstadienone, but not for the reference odor phenylethyl alcohol, was bimodal, with a smaller group of individuals with a high sensitivity to androstadienone (supersmellers). A lack of correlation between thresholds for androstadienone and phenylethyl alcohol further suggested that the bimodality for androstadienone was not due to individuals with a high general olfactory sensitivity. In line with an earlier observation, there was a statistical tendency for women to be more sensitive to androstadienone than men. Results of experiment 3 preclude the possibility that the bimodal sensitivity distribution for androstadienone would depend on individual differences in trigeminal activation. Altogether, the current study suggests that olfactory sensitivity to androstadienone is bimodally distributed in the population with a subgroup consisting of highly sensitive people.
Research on human chemosignals (so-called pheromones) has recently focused on the steroids 4,16-androstadien-3-one (androstadienone) and 1,3,5(10),16-estratetraen-3-ol (estratetraenol). It has been reported that androstadienone affects subjects’ mood (Jacob and McClintock, 2000; Lundstrom et al., 2003), psychophysiological responses (Grosser et al., 2000; Jacob et al., 2001a) and brain activity (Jacob et al., 2001b; Savic et al., 2001). Androstadienone is a member of the family of odorous 16-androstenes and can be found in the peripheral blood plasma of men to the extent of 98 ng/100 ml blood (Brooksbank et al., 1972) and in their axillary secretion with a mean value of 228 pmol/total axillary hair weight (Nixon et al., 1988). Androstadienone can also be found in women, but at a much smaller concentration (Brooksbank et al., 1972). Male axillae are said to be dominated by coryneform bacteria, while women’s axillae microflora are said to be dominated by micrococcacea bacteria (Jackman and Noble, 1983). Although examined in only a few subjects, it has been shown that there is a high correlation between the presence of coryneform bacteria and the amount of 5α-androst-16-en-3-one (androstenone) (Gower and Ruparelia, 1993). Based on this, it has been proposed that androstadienone may be created from androstadienol by axillary coryneform bacteria and is later transformed into the more odorous androstenone (Mallet et al., 1991; Rennie et al., 1991). It is therefore conceivable that androstadienone may be a precursor to many of the other 16-androstenes (Gower and Ruparelia, 1993). Compared to androstadienone, the steroid estratetraenol has been investigated to a lesser degree. Estratetraenol has been found to affect subjects’ mood (Jacob and McClintock, 2000), psychophysiological recordings (Jacob et al., 2001a) and brain activity in males (Savic et al., 2001). Estratetraenol is a compound that is structurally similar to estrogens. However, with regard to being a compound of human origin, estratetraenol has only been isolated from urine of pregnant women in the third trimester (Thysen et al., 1968).
An interesting aspect of the notion of putative human pheromones relates to the question whether they exert their effects due to conscious experience of the exposure or not. It has been clearly shown that consciously perceived, non-pheromonal odorants can modulate behavior (Baron, 1988). Until today, studies on potential putative human pheromones have failed to determine to what extent the compound in question could be consciously experienced (Benton, 1982; Benton and Wastell, 1986; Cutler et al., 1998; Thorne et al., 2002). Surprisingly, none of the published studies on potential putative human pheromones has used proper psychophysical testing to ascertain that the concentration of the putative pheromone in question is not above detection threshold, or that control odors are not discernible from the investigated putative pheromones.
One paper (Gower and Ruparelia, 1993) has been cited as a reference to the absolute threshold value of androstadienone. However, this reference is referring back to an article that investigated the olfactory threshold of androstenone and not androstadienone (Patterson and Griffiths, 1969). To our knowledge, there is only one peer-reviewed study aiming at the determination of androstadienone thresholds in humans. Koelega and Köster (1974) investigated potential sex differences in odor perception of several biological (odorants of human origin) and non-biological odors, including androstadienone. They reported that women had a generally higher sensitivity to biological odors than men and that there was a significant sex difference in the threshold for androstadienone where women had a threshold of 11.4 mM and men 19.5 mM. However, as the authors pointed out correctly, the method used in the study was acceptable in terms of determination of sex differences but was flawed with regard to determination of absolute thresholds.
The present paper reports results of three experiments on individual differences in androstadienone sensitivity. Since it is important to consider the contribution of consciousness when studying the effects of putative human pheromonal compounds, we conducted a study (experiment 1) with the aim of determining the absolute threshold for the two steroids androstadienone and estratetraenol. In experiment 2, we measured the threshold for androstadienone and the compound phenylethyl alcohol with a broader stimulus range than used in experiment 1 with the aim of assessing the potential bimodal sensitivity distribution of androstadienone. Finally, experiment 3 investigated potential trigeminal activation of the putative pheromonal compound androstadienone.
The experiment involved 42 healthy volunteers (22 women) with a mean age of 26.2 years (± 5.9 years). None of the participants reported nasal surgery. All subjects rated themselves as normosmic without any nasal problems. They were recruited through posters on the university campus and were rewarded with either a cinema voucher or course credits.
Androstadienone and estratetraenol were obtained from Steraloids Inc. with a purity of ≥98% (verified by Steraloids Inc.). The active compounds were dissolved in propylene glycol (purity ≥99%; VWR International), a relatively odorless and non-toxic liquid. Five concentrations of both androstadienone and estratetraenol were established using dilution steps with a 2.5-increase of liquid concentration (androstadienone: 76–3000 µM; estratetraenol: 192–7500 µM). These step sizes were based on a pilot study (n = 8) indicating that estratetraenol was not detectable at concentrations below 3000 µM. Two identical stimulus sets were prepared for each odorant. Each set consisted of the five concentrations mentioned above and one blank (referred to as target) each of which was pared with two controls (referred to as lure). The stimuli were presented from 250 ml polypropylene squeeze bottles with pop-up spouts. These were washed and air-dried before use in order to minimize the background odor, and filled with 15ml of the solution.
Thresholds for androstadienone and estratetraenol were measured on two different occasions in counterbalanced order using similar procedures. Threshold tests were of a three-alternative, forced-choice design using one target and two control bottles placed on a table at three fixed positions. The presentation order was randomized with regard to the presented concentration of the target and the position on the table. When all six concentrations of the stimuli had been presented once in the first set, the other set was used (and so forth) in order to allow the headspace in the bottles to saturate. Further, this use of two different sets also ensured that no single bottle would be presented twice successively. All three bottles of the individual stimuli were placed in front of the participant on marked, numbered, positions on the table and they were asked to sniff each bottle just once, in the order of presentation, by holding the bottle just below the nose and gently squeezing it once. They were told that one bottle in each trial was different and that they should pick the ‘odd’ one. No feedback was provided to the participants with regard to correct identification of the odor. After making a decision they were asked to rate the confidence in their choice on a labeled scale ranging from zero (absolutely uncertain) to five (absolutely certain). This continued until all six stimulus levels had been presented nine times each, summing up to a total of 54 trials. Before the test started, training trials with three blank bottles containing only propylene glycol were conducted in order to get the participants acquainted with the test procedure. Participants had a 5 min pause outside the testing facility in the middle of each session to counteract sensory adaptation; each session took ∼45 min.
For each participant and concentration, the proportion of correct responses was calculated. The proportion of correct responses for each individual was plotted against log odor concentration which yielded an ogive function. Logistic functions were fitted to the data and 66.6% thresholds were determined. Analyses of variance (ANOVA) were used to statistically test for group differences in threshold values.
The absolute threshold for androstadienone was 211 µM, expressed as concentration in solution (see Figure 1). The female participants had an absolute threshold value of 168 µM and the male participants 251 µM, which is a non-significant difference [F(1,39) = 0.42].
The threshold value obtained in this experiment for androstadienone is considerably lower than the threshold value previously reported by Koelega and Köster (1974). There may be several reasons for this discrepancy. The technique used by Koelega and Köster, as correctly stated by the authors, was not optimized for determination of absolute threshold values. Both stimulus presentation and preparation were different, which is known to have impact on individual thresholds (Pierce et al., 1996).
It was not possible to determine the detection threshold for the stimulus range of estratetraenol concentrations used in this study. None of the participants was able to detect estratetraenol at its highest concentration (7500 µM). This finding corroborates earlier observations indicating that estratetraenol is an odorless chemical compound (Koelega and Köster, 1974; Ohloff et al., 1983; Prelog et al., 1945). Unfortunately, these studies do not specify the dilution range used. However, Savic et al. (2001) state that crystalline estratetraenol has an odor which implies that the absolute threshold value for estratetraenol probably lies well above the highest dilution used in this study.
Previous studies on potential human pheromones focused on women not taking oral contraceptives. The present study yielded no evidence that the use of oral contraceptives (n = 12) affected olfactory sensitivity for androstadienone [F(1,19) = 0.90, n.s.].
The most common finding regarding confidence judgments in sensory discrimination tasks has been the underconfidence phenomenon (Bjorkman et al., 1993; Juslin et al., 1998), where the mean probability of being correct assumed by the participant, X, falls short of the actual proportion correct discriminations, C. Confidence is commonly measured by this difference, X – C, and expressed as an Over- or Underconfidence score, O/U. The participants are said to be calibrated to the extent that the proportion correct in each confidence category matches the subjective probability of that category. Participant’s confidence judgments in this experiment were well calibrated with regard to their actual performance (O/U = –0.03). As stated above, participants are often underconfident in most sensory tasks. However, the participants in this study were not. Conscious experience and behavioral discrimination concurred. This implies that the use of verbal descriptors for measurement of discriminatory performance between the test and control stimuli employed, among others, by Jacob and colleagues in their studies (Jacob et al., 2001a; Jacob and McClintock, 2000), could be accurate measurements of conscious discriminatory performance. However, verbal discrimination puts high demands on memory and accuracy of verbal descriptors (White, 1998). Therefore, a discriminatory test where participants are able to make a direct comparison between test and control solution may still be recommended if the aim of the study is to present solutions that cannot be discriminated by the participants. A suggestion of such a test has been made elsewhere (Lundstrom et al., 2003). When performance on each concentration level was considered, we observed that some participants at the lowest stimulus level (76 µM) could clearly sense the concentration easily and consequently expressed a high level of confidence. This finding corroborated earlier findings that some participants show a high sensitivity to androstadienone (Lundstrom et al., 2003). However, whether these highly sensitive ‘supersmellers’ really had a specific sensitivity for androstadienone or whether they just had a generally high olfactory acuity was not clear. Another question concerns whether the existence of supersmellers indicates a bimodal sensitivity distribution or created by a cutoff effect of the normal distribution curve.
To summarize: the absolute threshold for androstadienone is 211 µM. The relation between participants’ sensory discrimination and conscious perception seemed to be well calibrated. Finally, it was not possible to determine an absolute threshold for estratetraenol for the range of concentrations used.
Extensive psychophysical work has been done on the related steroid androstenone. Several studies have shown that many normal adults cannot detect the characteristic urinous odor of androstenone. Around 40–50% of the population has a low sensitivity/specific anosmia towards androstenone (Labows and Wysocki, 1984; Wysocki and Beauchamp, 1991), which appears to have both a genetic (Wysocki and Beauchamp, 1984) and a developmental component (Dorries et al., 1989). As androstadienone probably is a precursor to androstenone, it is conceivable that a similar bimodality exists for the olfactory sensitivity to androstadienone. However, the results of experiment 1 suggested that there are two sensitive groups, one smaller group that is more sensitive and one larger that is less sensitive. Bimodality of sensitivity composing clearly sensitive groups has been reported in the literature before for the odors of methylmercaptan and acetone (Lison et al., 1980; Odeigah, 1994).
The first aim of experiment 2 was to investigate whether there is a bimodal sensitivity distribution for androstadienone thresholds. The second aim was to correlate individual sensitivity to androstadienone with sensitivity to phenylethyl alcohol in order to investigate whether potential supersmellers are specifically sensitive to androstadienone or whether they have a higher olfactory sensitivity in general.
In experiment 2, 100 people participated, with a mean age of 24 ± 3.9 years (58 women: mean age 24 ± 4.2; 42 men: mean age 24 ± 3.5). They were all recruited through posters on the campus. Inclusion criteria were self-reported absence of nasal congestion, infection or decreased olfactory function at the time of the testing. Twenty-six participants had some form of allergy but showed no signs of this at the time of testing; 13 participants labeled themselves as smokers. Having an allergy or using tobacco products did not have a significant effect on either phenylethyl alcohol (all t < 0.41, all P > 0.34), or androstadienone thresholds (all t < 1.57, all P > 0.12). Participants were asked not to drink anything other than water, not to use any form of tobacco products for 1 h before testing and not to wear perfume during the experiment. After completion of the testing, participants were rewarded with a cinema voucher.
Two different olfactory threshold tests were used to assess participants’ olfactory abilities. The ‘Sniffin’ Sticks’ set (for a detailed instruction of the Sniffin’ Sticks, see Hummel et al., 1997), felt-tip pens filled with phenylethyl alcohol diluted in propylene glycol, was used to investigate olfactory function of the participants using a ‘non-biological’ odor. The set contained 16 concentrations of phenylethyl alcohol dissolved in logarithmic steps with a stimulus range from 16.3 µM (dilution 16) to 0.54 M (dilution 1).
Androstadienone was obtained, dissolved and handled the same way as described in experiment 1. The exception was that the solution was dissolved into 16 concentrations with a 2-fold increase of liquid concentration, ranging from 0.091 µM (dilution 16) to 3000 µM (dilution 1), in order to match the concentration steps used in the Sniffin’ Sticks set and to be sure to cover the whole sensitivity range of all individuals. Two identical sets were alternatively used also in this experiment.
Each session was divided into two blocks for threshold measurements for androstadienone or phenylethyl alcohol, randomized with respect to starting order.
Participants were blindfolded with a sleeping mask in order to prevent any visual discrimination of the odor probes. They were presented with triplets of odorants where each individual odor probe was presented, in randomized order, for ∼3 s with at least 30 s between the triplets. Only one of the probes in each triplet contained phenylethyl alcohol in different concentrations and the other two contained only the solvent, propylene glycol. Using a forced-choice paradigm, participants had to find out which one of the three probes smelled differently. The triplets were presented only once. Pens were presented in ascending concentrations until the participant had correctly discerned the odorant in two successive trials which then triggered a reversal of the staircase. The test ended after the seventh reversal of the staircase and took on average 30 min (Ehrenstein and Ehrenstein, 1999).
Regarding threshold measurements for androstadienone, we used the same presentation technique as described in experiment 1 with the important exception that this time we used the same ascending staircase paradigm as describe above for the Sniffin’ Sticks. Other than in experiment 1, participants did not make any confidence judgments. At the end of the experiment, they rated their hedonic perception of both phenylethyl alcohol and androstadienone on a 10 cm visual analog scale (VAS) ranging from ‘extremely unpleasant odor’ to ‘extremely pleasant odor’.
The mean of the last four staircase reversal points was used as threshold estimate for both androstadienone and phenylethyl alcohol. The differences between groups were assessed using Student’s t-test. Analyses of variance (ANOVA) were used to statistically test for differences between groups and interaction effects. Pearson correlation statistics were used in all correlation analyses presented.
A statistical test for bimodality, the DIP intensity test (Giacomelli et al., 1971), was used in order to evaluate the significance of the possibly bimodal sensitivity distribution of androstadienone. The DIP intensity test is a measure of the mean spacing between points in the gap divided by the dispersion of the data. The test does not depend on prior classification of cells and is a highly conservative measure of bimodality since the underlying assumption is a uniform distribution and not a gaussian distribution.
Mean thresholds for androstadienone and phenylethyl alcohol, expressed in dilution steps, were 9.4 (SEM ± 0.32) and 7.8 (SEM ± 0.30), respectively. The sensitivity distributions of the two odorants are illustrated in Figure 2A,B. Visual inspection suggests that the sensitivity distribution for androstadienone, but not for phenylethyl alcohol, is bimodal.
Two different methods of determining bimodality are currently often used in the literature. One is primarily graphical and relies upon the existence of two modes in the distribution with a clearly visible antimode between these modes. The other definition is based on measures of variance and states that observations that lie two standard deviations from the mean are outliers and belong to another distribution—hence indicating a bimodal distribution. We see reliability problems with both of these methods. Interpretations using graphical methods are dependent on subjective decision criteria of bin sizes. Different bin sizes give different interpretations of the results at hand. Using the method of outliers is dependent on the relative size of the outlier group. In order to assess statistically whether the sensitivity distribution of androstadienone in this experiment is bimodal we used the DIP intensity test (Giacomelli et al., 1971). Since the test is unduly conservative if there are three modes or more, we excluded the three participants that were insensitive to androstadienone (no detection of the highest concentration) from the statistical analyses of bimodality. The DIP intensity test shows that the sensitivity distribution of androstadienone in experiment 2 is bimodally distributed (DIP = 2.07, P < 0.05).
The correlation between individual thresholds for androstadienone and phenylethyl alcohol was close to zero [r(100) = 0.03, n.s.]. This indicates that the bimodality seen for androstadienone cannot be explained by a general bimodality in olfactory acuity in the sample. This is also evident in the lack of bimodality for phenylethyl alcohol. It should be noted that correlations for individual thresholds between odorants are generally much higher. For example, Cain and Gent (1991) measured thresholds for four odorants; correlations ranged from 0.66 to 0.86 for all six combinations.
Androstadienone and phenylethyl alcohol were perceived differently in hedonic tones by the participants. In general, androstadienone was perceived as unpleasant (mean rating, 4; SD ± 1.91) and phenylethyl alcohol was perceived as pleasant (mean rating, 6.8; SD ± 2.05). The correlation between hedonic rating and individual threshold was low for androstadienone [r(100) = –0.07, n.s.], but slightly higher for phenylethyl alcohol [r(100) = 0.20, P = 0.05]. It could be noted that a significant correlation between olfactory threshold and hedonic ratings has been observed for the related compound androstenone (Dorries et al., 1989; Wysocki and Beauchamp, 1991).
Several studies report that women tend to have a higher olfactory sensitivity than males (Doty, 1986). Here, there was a tendency for women to have a higher sensitivity to androstadienone than men [mean threshold women, 8.28, SEM ± 0.42; men, 7.17, SEM ± 0.43; t(98) = 1.79, P = 0.08], but not for phenylethyl alcohol [mean threshold women, 9.17, SEM ± 0.46; men, 9.84, SEM ± 0.45, t(98) = 1.02, n.s.]. The interaction between substance and sex was, however, significant [F(1,98) = 4.12, P = 0.04].
To summarize: experiment 2 shows that the sensitivity distribution is bimodal for androstadienone, but not for phenylethyl alcohol. This bimodality cannot be explained by a subgroup of subjects with a general high olfactory sensitivity since there is no correlation between individual thresholds. Accordingly, the supersmellers do not posses a generally high olfactory sensitivity, as judged by phenylethyl alcohol odor thresholds, but rather exhibit a specific sensitivity towards androstadienone.
As presented above, other odors have previously been reported to have a bimodal sensitivity distribution with one mode that consists of more sensitive individuals. What these bimodal odors all have in common is that they have a high trigeminal factor (Doty et al., 1978). The possibility therefore arises that the demonstrated bimodality in the literature for these odors, as well as the bimodality for androstadienone in this study, are due to the fact that some people have a more sensitive trigeminal system than others (Hummel et al., 2003). The trigeminal system in man is an integrated part of our olfactory perception and mediates sensations such as burning, stinging, warmth, coolness or itching (Hummel, 2000). It is comprised of two major fiber systems, unmyelinated C-fibers and myelinated Adelta-fibers (Anton and Peppel, 1991) where C-fibers are involved in the mediation of dull, burning sensations and Adelta-fibers mediate sharp and stinging sensations (Torebjork and Hallin, 1974).
When purely olfactory stimuli are presented to one nostril, while the other nostril receives an equal amount of non-odorized air, it is impossible to make correct lateralization judgments (Kobal et al., 1989). Correct lateralization of intranasal stimuli is believed to be due to trigeminal chemoreception based on the fact that neither feedback nor training enhances performance above chance level (Radil and Wysocki, 1998; Wysocki et al., 2003). This disparity between the olfactory and trigeminal system makes it possible to use lateralization judgments as a means to assess the trigeminal impact of an odor (Hummel et al., 2003). In experiment 3, we therefore sought to investigate the possibility that the demonstrated bimodality of androstadienone is due to a subgroup of individuals with high trigeminal sensitivity that reacts to a potential trigeminal, and not olfactory, aspect of androstadienone.
We recruited 20 participants from those that had participated in experiment 2. Ten of these belonged to the sensitive group in the distribution. That is, they had threshold values for androstadienone in the interval of 10–12 dilution steps (mean threshold 11.3; mean age 23 years). Further, we recruited 10 participants who belonged to the normal group having a threshold value for androstadienone in the interval of 4–8 dilution steps (mean threshold 6.5; mean age 24.6 years). The two groups were balanced for sex and all participants were rewarded with a cinema voucher.
Two identical sets, each containing two plastic squeeze bottles, as described above with the exception of a longer spout, were prepared. Each set consisted of one bottle with 30 ml of 3000 µM androstadienone, dissolved in propylene glycol (purity ≥99%), and one with 30 ml propylene glycol. The stimuli were presented to the participants via a hand-held device that ensured an equal airflow of ∼15 ml air into each nostril (device and method is described in Hummel et al., 2003).
The spouts of the two bottles were placed in the nostrils. Androstadienone was presented to one nostril and pure propylene glycol to the contralateral nostril in a randomized order. The experimenter pressed the hand-held squeezing device containing the two bottles which rendered a puff of air into each nostril at the same time. Participants held onto the spouts to prevent movements that might interfere with their ability to correctly localize the odor by producing mechanical irritation. Forty stimuli (20 targets to each nostril) were presented at an interstimulus interval of ∼30 s in order to allow the trigeminal system to recover (Hummel and Kobal, 1998). After each stimulus presentation participants were asked to identify the nostril where the odorant had been presented and also to rate their confidence as described in experiment 1. Stimulus sets were changed in the middle of the session to an unused set in order to maximum the possibility for correct lateralization judgments. Each session required ∼30 min of testing.
The difference between means based on the sum of correct lateralization judgments was assessed using Student’s t-tests.
We found no evidence of a trigeminal sensation of androstadienone at 3000 µM. The mean correct lateralization score was 20.3 (SEM ± 0.79) for the whole group, which was not significantly different from chance level (i.e. 20) [t(19) = 0.39, n.s.]. Participants were well calibrated in respect of confidence judgments of their performance (O/U = –0.01). Furthermore, there was no significant difference between groups of different androstadienone sensitivity. The supersmellers had a mean correct lateralization score of 19.4 (SEM ± 0.88) and the normal group 21.2 [SEM ± 1.23, t(18) = 1.18, n.s.]. The absence of trigeminal detection indicates that the bimodality in sensitivity to androstadienone is not due to a subgroup of participants with an extra sensitive trigeminal system that reacts to a trigeminal component of androstadienone rather than an olfactory one.
The current study investigated individual differences in absolute sensitivity to the putative human pheromone androstadienone. Using the method of constant stimuli, the absolute threshold for androstadienone was determined to be 211 µM (concentration in solution). Several studies have investigated the effects of androstadienone exposure on mood and psychophysiology using 250 µM with or without an odor mask (Grosser et al., 2000; Jacob and McClintock, 2000; Jacob et al., 2001a,b, 2002; Lundstrom et al., 2003). In a recent study (Lundstrom et al., 2003), supersmellers were able to detect the odor of androstadienone despite a 1% eugenol odor mask. Since some individuals seem to have a specific sensitivity to androstadienone, particular attention must be paid when adjusting the concentration levels when behavioral or physiological effects of non-conscious/non-discriminable exposure of androstadienone are investigated. Although detection of androstadienone could not be tied to the observed effects on mood in the mentioned study, we still maintain that a proper odor discrimination test between test and control odors should be used when measuring exposure effects of putative pheromones.
Several odors have been proven to have a bimodal sensitivity distribution. Only a few of these (see above) are bimodally distributed such that both groups exhibit different sensitivity. For the other bimodal odors (for a review, see Amoore, 1977), bimodality depends on a group of individuals with specific anosmia to the particular odorant, although the choice of stimulus concentration range is of course crucial for this conclusion. From experiment 3 of the current study, it is clear that the observed bimodality is not due to variations in trigeminal sensitivity and therefore most likely of an olfactory origin. Whether this specific sensitivity to androstadienone is due to exposure-induced changes at the receptor level or to genetic factors, as has been suggested for androstenone (Wysocki and Beauchamp, 1984; Yee and Wysocki, 2001), remains to be determined.
Although not significant, the overall results regarding sex differences in olfactory sensitivity to androstadienone in both experiments 1 and 2 point in the direction that women are nominally more sensitive to this putative pheromone than are men. Sex differences in olfaction are largely restricted to tasks that require higher cognitive processing such as odor identification and memory (Doty et al., 1984; Oberg et al., 2002). However, Koelega and Köster (1974) also found that women were in fact more sensitive to androstadienone and other odorants of biological origin than were male participants. However, the sex difference was not present in pre-pubertal children. Dalton et al. (2002) showed that an increased sensitivity due to repeated testing was observed among females of reproductive age but not in men. They hypothesized that sex-specific changes in sensitivity might be more likely to occur with biologically relevant odorants. Androstenone, for example, occurs at a higher concentration in male axillae and women are more likely to be normosmic to and to have lower thresholds for androstenone than men which might possible signify an induction of sensitivity in some women who are regularly exposed to male axillary odors. This supposed induction of sensitivity might also be the case for androstadienone. We believe that future studies on the nature of androstadienone sensitivity should focus on the effects of hormonal status and tests of induced sensitivity.
The main conclusion from the experiments presented above is that a subgroup within the population have a specific sensitivity to androstadienone. This is not due to a higher general olfactory acuity or higher trigeminal sensitivity.
Source:
© 2022 - 2024
All rights reserved by
singlepheromones.com